Caffeic acid and its derivatives as multifunctional anticancer agents: From mechanisms to clinical prospects
- 14 January 2026
- journal article
- Published by Elsevier in PharmaNutrition
- Vol. 35
Abstract
No abstract availableFunding Information
- Bharati Vidyapeeth
This publication has 45 references indexed in Scilit:
- Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathwayBiomedicine & Pharmacotherapy, 2024
- Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer's disease therapyColloids and Surfaces B: Biointerfaces, 2023
- Caffeic acid, a dietary polyphenol, as a promising candidate for combination therapyChemical Papers, 2021
- A review on the role of TANK-binding kinase 1 signaling in cancerInternational Journal of Biological Macromolecules, 2021
- Caffeic acid phenethyl ester mitigates cadmium-induced hepatotoxicity in mice: Role of miR-182-5p/TLR4 axisEcotoxicology and Environmental Safety, 2021
- Pharmacological significance of the non-canonical NF-κB pathway in tumorigenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- Antiproliferative and apoptotic effects of caffeic acid on SK-Mel-28 human melanoma cancer cellsMolecular Biology Reports, 2019
- Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancerGenes & Nutrition, 2015
- Cyanidin suppresses ultraviolet B-induced COX-2 expression in epidermal cells by targeting MKK4, MEK1, and Raf-1Biochemical Pharmacology, 2010
- Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human faecal microbiota in vitroBiomedicine & Pharmacotherapy, 2006